OR Technology Group has sold its shares to a fund advised by NORD Holding, positioning itself for significant growth in the medtech sector.
Target Information
The OR Technology Group is a leading European medtech platform specializing in digital solutions that encompass AI-driven software, high-quality hardware, and comprehensive service offerings for diagnostic imaging in veterinary medicine as well as selected human medicine segments. With over 30 years of industry experience and more than 10,000 installed systems, OR Technology boasts a scalable and high-margin business model. The company is committed to significant growth potential both domestically and internationally, which is driven by organic expansion and a targeted M&A strategy.
In 2020, an investor group advised by Rigeto Unternehmerkapital acquired a majority stake in Oehm und Rehbein, further consolidating its position in the market. In March 2022, OR Technology enhanced its capabilities by acquiring Celtic SMR, a leading value-add distributor in the veterinary medicine sector in the UK. The leadership transition was marked in 2024 with Tim Thurn's appointment as CEO, alongside further advancements in sales, development, product management, and assembly operations at its primary facility in Rostock.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Germany
Germany remains a powerhouse in the European medtech industry, characterized by its rigorous regulatory environment and robust innovation capabilities. With a strong emphasis on research and development, the country has established itself as a hub for com
Similar Deals
NORD Holding
invested in
OR Technology Group
in 2025
in a Buyout deal